iobenguane: clinical use

Prescribing considerations

• Justify each exposure individually and minimise radiation while retaining diagnostic image quality.
• Review substances that may alter uptake before scheduling.
• Ensure hydration, thyroid blockade and appropriate radiation precautions.
• Carefully assess renal or hepatic impairment because radiation exposure may be increased.
• Use only in authorised nuclear medicine settings with resuscitation facilities immediately available.

Contraindications and cautions

• Hypersensitivity to iobenguane or any excipient.
• Premature babies and neonates.
• Benzyl alcohol requires particular caution in children aged under three years.

Monitoring

• Confirm pregnancy and breastfeeding status where relevant.
• Monitor continuously during slow intravenous administration for hypersensitivity, palpitations and hypertension.
• Consider renal and hepatic function when assessing radiation risk.
• Document the radiopharmaceutical and provide locally determined contact and excretion precautions.

Clinical pharmacology

Iobenguane is a radioiodinated aralkylguanidine related to guanethidine and noradrenaline. It undergoes active neuronal uptake and enters intracellular storage granules. Elimination is predominantly renal, largely as unchanged compound.

Formulation and product differences

• The selected product is a clear, colourless iodine-123 solution for slow intravenous injection or infusion.
• It contains benzyl alcohol and sodium, which may be relevant in young children or people requiring sodium restriction.
• It must not be mixed with other medicinal products without compatibility data.